Literature DB >> 2122465

Differentiation of F9 embryonal carcinoma cells induced by the c-jun and activated c-Ha-ras oncogenes.

Y Yamaguchi-Iwai1, M Satake, Y Murakami, M Sakai, M Muramatsu, Y Ito.   

Abstract

The activated c-Ha-ras oncogene induced AP1-site DNA-binding activity in F9 cells. This induction appeared to be due, at least in part, to the induction of c-jun transcription. Both activated c-Ha-ras and c-jun induced the differentiation of F9 cells to endoderm-like cells. Thus, AP1 appears to play a key role in the initial stage of F9 cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122465      PMCID: PMC55019          DOI: 10.1073/pnas.87.21.8670

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  A ubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors.

Authors:  K Furukawa; Y Yamaguchi; E Ogawa; K Shigesada; M Satake; Y Ito
Journal:  Cell Growth Differ       Date:  1990-03

2.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

3.  T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes.

Authors:  E Santos; S R Tronick; S A Aaronson; S Pulciani; M Barbacid
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

4.  Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1).

Authors:  D Solter; B B Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

5.  Mouse actin messenger RNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse alpha-actin mRNA.

Authors:  A J Minty; M Caravatti; B Robert; A Cohen; P Daubas; A Weydert; F Gros; M E Buckingham
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

Review 6.  Teratocarcinomas and mammalian embryogenesis.

Authors:  G R Martin
Journal:  Science       Date:  1980-08-15       Impact factor: 47.728

7.  Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes.

Authors:  R Müller; E F Wagner
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

8.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  L A Greene; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

9.  Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation.

Authors:  D Bar-Sagi; J R Feramisco
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

10.  Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells.

Authors:  U Rüther; E F Wagner; R Müller
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

View more
  12 in total

1.  Characterization of a DNA-damage-recognition protein from F9 teratocarcinoma cells, which is inducible by retinoic acid and cyclic AMP.

Authors:  C C Chao; N K Sun; S Lin-Chao
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

2.  Functional specificity of ras isoforms: so similar but so different.

Authors:  Esther Castellano; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

3.  The kinetics of induction of Hox1.6 and C-jun mRNA during three different ways of inducing differentiation in teratocarcinoma F9 cells.

Authors:  S A Iwai; Y Nishina; M Kosaka; T Sumi; T Doi; M Sakuda; Y Nishimune
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-06       Impact factor: 2.416

4.  Induction, not associated with host-cell re-activation of damaged plasmid DNA, of damaged-DNA-recognition proteins by retinoic acid and dibutyryl cyclic AMP in mammalian cells.

Authors:  N K Sun; S L Huang; S Lin-Chao; C C Chao
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

5.  The nuclear protooncogenes c-jun and c-fos as regulators of DNA replication.

Authors:  Y Murakami; M Satake; Y Yamaguchi-Iwai; M Sakai; M Muramatsu; Y Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

6.  JDP2, a repressor of AP-1, recruits a histone deacetylase 3 complex to inhibit the retinoic acid-induced differentiation of F9 cells.

Authors:  Chunyuan Jin; Hongjie Li; Takehide Murata; Kailai Sun; Masami Horikoshi; Robert Chiu; Kazunari K Yokoyama
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

7.  A novel pathway for retinoic acid-induced differentiation of F9 cells that is distinct from receptor-mediated trans-activation.

Authors:  I Kitabayashi; R Chiu; K Umesono; R M Evans; G Gachelin; K Yokoyama
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-11       Impact factor: 2.416

8.  Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion.

Authors:  Margaret P Quinlan; Steven E Quatela; Mark R Philips; Jeffrey Settleman
Journal:  Mol Cell Biol       Date:  2008-02-11       Impact factor: 4.272

9.  Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction.

Authors:  S Vainikka; J Partanen; P Bellosta; F Coulier; D Birnbaum; C Basilico; M Jaye; K Alitalo
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  Transcriptional regulation of the c-jun gene by retinoic acid and E1A during differentiation of F9 cells.

Authors:  I Kitabayashi; Z Kawakami; R Chiu; K Ozawa; T Matsuoka; S Toyoshima; K Umesono; R M Evans; G Gachelin; K Yokoyama
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.